FDA Inspection 1280989 — Idaho Center for Reproductive Medicine
The FDA completed an inspection of Idaho Center for Reproductive Medicine on August 29, 2025 in Boise, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 29, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Boise, ID (United States)